Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.

Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check4 days agoChange DetectedNo substantive changes detected; the screenshots show only minor visual adjustments and no edits to core study content, eligibility criteria, endpoints, or the list of locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedOnly the Study Record Dates timestamp appears to have been updated; no substantive changes to eligibility, locations, enrollment, or outcomes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedLocations section was added and reorganized to include site listings across multiple regions (California, New York, North Carolina, Ohio, Texas, Wisconsin, New South Wales, Ontario); older location entries were removed. The page now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure footer link has been removed.SummaryDifference1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedCore study information such as design, eligibility criteria, primary and secondary outcomes, and locations remains unchanged; only minor UI/layout differences are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedPage revision label updated from v3.3.1 to v3.3.2 in the header/footer; no study content or data were changed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed; there is no visible change to the study details or user-facing features.SummaryDifference0.1%

Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.